Bristol-Myers (BMY) Lung Cancer Drug Successful In Late-Stage Trial

January 12, 2015 12:22 PM

17 0

The late-stage trial for Bristol-Myers’ lung cancer treatment Opdivo was terminated after the drug showed superior survival rates in patients

Bristol-Myers Squibb Co (NYSE:BMY) announced yesterday that the Phase-III trial of its experimental lung-cancer treatment Opdivo has been terminated earlier-than-anticipated. The termination came after an independent monitoring committee concluded that the said drug had superior efficacy results, as...

Read more

To category page